When lactic acid from tumor cells is transported to the tumor microenvironment through the lactate transporter SLC16A7, it can induce the conversion of M0 macrophages to the M2 type, suppressing the body’s immune function. This evidence concerns the gene SLC16A7 and neoplasm.